VIRPAX PHARMACEUTICALS INC (VRPX) Stock Price, Quote, News and Overview
NASDAQ:VRPX - Nasdaq - US9282512063 - Common Stock - Currency: USD
VRPX Quote, Performance and Key Statistics
0.6695
-0.55 (-45.12%)
The current stock price of VRPX is 0.6695 USD. In the past month the price decreased by -85.68%. In the past year, price decreased by -99.31%.
VRPX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 68.04 | 838.54B | ||
| JNJ | JOHNSON & JOHNSON | 15.38 | 372.51B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 17.99 | 275.58B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.12 | 221.49B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 16.76 | 215.69B | ||
| MRK | MERCK & CO. INC. | 10.62 | 208.21B | ||
| PFE | PFIZER INC | 7.37 | 129.99B | ||
| SNY | SANOFI-ADR | 13.59 | 128.08B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.53 | 97.47B | ||
| GSK | GSK PLC-SPON ADR | 8.6 | 75.84B | ||
| ZTS | ZOETIS INC | 25.92 | 68.46B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 32.67 | 47.30B |
Related stock screener links
About VRPX
Company Profile
Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. The company is headquartered in Berwyn, Pennsylvania and currently employs 2 full-time employees. The company went IPO on 2021-02-17. The firm is focused on developing novel and proprietary drug delivery systems across various pain indication. Its drug-delivery systems and drug-releasing technologies being developed are focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system (CNS) disorders to enhance patients’ quality of life. Its portfolio consists of multiple preclinical stage product candidates: Epoladerm, Probudur, Envelta, AnQlar and NobrXiol. Probudur is a single injection liposomal bupivacaine formulation being developed to manage post-operative pain. Envelta is an intranasal molecular envelope enkephalin formulation being developed to manage acute and chronic pain, including pain associated with cancer. The NobrXiol is being developed for the nasal delivery of a pharmaceutical-grade cannabidiol (CBD) for the management of rare pediatric epilepsy.
Company Info
VIRPAX PHARMACEUTICALS INC
1055 Westlakes Drive, Suite 300
Berwyn PENNSYLVANIA 19380 US
CEO: Anthony Mack
Employees: 7
Company Website: https://virpaxpharma.com/
Investor Relations: http://ir.virpaxpharma.com
Phone: 16107274597
VIRPAX PHARMACEUTICALS INC / VRPX FAQ
What is the stock price of VIRPAX PHARMACEUTICALS INC today?
The current stock price of VRPX is 0.6695 USD. The price decreased by -45.12% in the last trading session.
What is the ticker symbol for VIRPAX PHARMACEUTICALS INC stock?
The exchange symbol of VIRPAX PHARMACEUTICALS INC is VRPX and it is listed on the Nasdaq exchange.
On which exchange is VRPX stock listed?
VRPX stock is listed on the Nasdaq exchange.
What is VIRPAX PHARMACEUTICALS INC worth?
VIRPAX PHARMACEUTICALS INC (VRPX) has a market capitalization of 856.96K USD. This makes VRPX a Nano Cap stock.
How many employees does VIRPAX PHARMACEUTICALS INC have?
VIRPAX PHARMACEUTICALS INC (VRPX) currently has 7 employees.
Should I buy VIRPAX PHARMACEUTICALS INC (VRPX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of VRPX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of VRPX, evaluating the profitability, health, valuation and growth aspects
- VIRPAX PHARMACEUTICALS INC (VRPX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- VIRPAX PHARMACEUTICALS INC (VRPX) Sales and EPS estimates to see what analysts future expectations are.
- VIRPAX PHARMACEUTICALS INC (VRPX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- VIRPAX PHARMACEUTICALS INC (VRPX) Insider and Institutional Ownership to learn about the owners and their transactions.
- VIRPAX PHARMACEUTICALS INC (VRPX) Stock Chart to make your own analysis
- VIRPAX PHARMACEUTICALS INC (VRPX) Latest news and press-releases to stay up to date.
Does VIRPAX PHARMACEUTICALS INC (VRPX) stock pay dividends?
VRPX does not pay a dividend.
What is the Price/Earnings (PE) ratio of VIRPAX PHARMACEUTICALS INC (VRPX)?
VIRPAX PHARMACEUTICALS INC (VRPX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-5.29).
VRPX Technical Analysis
VRPX Financial Highlights
Over the last trailing twelve months VRPX reported a non-GAAP Earnings per Share(EPS) of -5.29. The EPS increased by 59.22% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -775.73% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
VRPX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to VRPX. The Buy consensus is the average rating of analysts ratings from 6 analysts.